25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Pharma Mar SAU
Buy, Hold or Sell?

Let's analyze Pharma Mar SAU together

I guess you are interested in Pharma Mar SAU. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pharma Mar SAU. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pharma Mar SAU

I send you an email if I find something interesting about Pharma Mar SAU.

1. Quick Overview

1.1. Quick analysis of Pharma Mar SAU (30 sec.)










1.2. What can you expect buying and holding a share of Pharma Mar SAU? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
€10.34
Expected worth in 1 year
€8.98
How sure are you?
65.0%

+ What do you gain per year?

Total Gains per Share
€-1.36
Return On Investment
-1.7%

For what price can you sell your share?

Current Price per Share
€79.75
Expected price per share
€65.21 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharma Mar SAU (5 min.)




Live pricePrice per Share (EOD)
€79.75
Intrinsic Value Per Share
€-5.10 - €-6.12
Total Value Per Share
€5.24 - €4.22

2.2. Growth of Pharma Mar SAU (5 min.)




Is Pharma Mar SAU growing?

Current yearPrevious yearGrowGrow %
How rich?$191.6m$227.8m-$23.5m-11.5%

How much money is Pharma Mar SAU making?

Current yearPrevious yearGrowGrow %
Making money-$465.1k$5.5m-$5.9m-1,285.0%
Net Profit Margin-1.0%11.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharma Mar SAU (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#263 / 959

Most Revenue
#139 / 959

Most Profit
#152 / 959

Most Efficient
#162 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharma Mar SAU?

Welcome investor! Pharma Mar SAU's management wants to use your money to grow the business. In return you get a share of Pharma Mar SAU.

First you should know what it really means to hold a share of Pharma Mar SAU. And how you can make/lose money.

Speculation

The Price per Share of Pharma Mar SAU is €79.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharma Mar SAU.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharma Mar SAU, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €10.34. Based on the TTM, the Book Value Change Per Share is €-0.34 per quarter. Based on the YOY, the Book Value Change Per Share is €0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharma Mar SAU.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.070.1%-0.030.0%0.270.3%0.861.1%0.861.1%
Usd Book Value Change Per Share-0.70-0.9%-0.36-0.4%0.060.1%0.550.7%0.550.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.110.1%0.110.1%
Usd Total Gains Per Share-0.70-0.9%-0.36-0.4%0.060.1%0.660.8%0.660.8%
Usd Price Per Share34.34-35.55-51.07-51.18-51.18-
Price to Earnings Ratio115.20-58.50-64.50-33.57-33.57-
Price-to-Total Gains Ratio-48.99-80.17-15.61-38.10-38.10-
Price to Book Ratio3.14-3.07-4.03-4.37-4.37-
Price-to-Total Gains Ratio-48.99-80.17-15.61-38.10-38.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share84.26385
Number of shares11
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.11
Usd Book Value Change Per Share-0.360.55
Usd Total Gains Per Share-0.360.66
Gains per Quarter (11 shares)-3.947.26
Gains per Year (11 shares)-15.7729.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-16-2652419
20-32-42104848
30-47-58157277
40-63-742096106
50-79-9025120135
60-95-10630144164
70-110-12235168193
80-126-13840192222
90-142-15445216251
100-158-17050240280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%18.02.00.090.0%18.02.00.090.0%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%13.07.00.065.0%13.07.00.065.0%13.07.00.065.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%6.00.014.030.0%6.00.014.030.0%6.00.014.030.0%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%13.07.00.065.0%13.07.00.065.0%13.07.00.065.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pharma Mar SAU compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.663-0.339-49%0.052-1371%0.517-228%0.517-228%
Book Value Per Share--10.34210.975-6%11.957-14%8.395+23%8.395+23%
Current Ratio--2.5502.703-6%2.952-14%2.674-5%2.674-5%
Debt To Asset Ratio--0.4280.423+1%0.426+0%0.576-26%0.576-26%
Debt To Equity Ratio--0.7480.734+2%0.744+1%1.653-55%1.653-55%
Dividend Per Share----0%-0%0.108-100%0.108-100%
Eps--0.071-0.025+135%0.255-72%0.813-91%0.813-91%
Free Cash Flow Per Share---0.675-0.421-38%-0.194-71%0.759-189%0.759-189%
Free Cash Flow To Equity Per Share---0.675-0.421-38%-0.107-84%0.499-235%0.499-235%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.120--------
Intrinsic Value_10Y_min---5.100--------
Intrinsic Value_1Y_max---0.137--------
Intrinsic Value_1Y_min---0.135--------
Intrinsic Value_3Y_max---0.776--------
Intrinsic Value_3Y_min---0.733--------
Intrinsic Value_5Y_max---1.851--------
Intrinsic Value_5Y_min---1.687--------
Market Cap1385672200.000+59%570014477.500592947469.775-4%872534571.940-35%888807740.880-36%888807740.880-36%
Net Profit Margin--0.029-0.010+133%0.118-75%0.243-88%0.243-88%
Operating Margin----0%0.006-100%0.211-100%0.211-100%
Operating Ratio--1.0661.129-6%0.961+11%0.854+25%0.854+25%
Pb Ratio7.712+59%3.1433.072+2%4.029-22%4.373-28%4.373-28%
Pe Ratio282.685+59%115.20158.495+97%64.500+79%33.570+243%33.570+243%
Price Per Share79.750+59%32.50033.645-3%48.335-33%48.437-33%48.437-33%
Price To Free Cash Flow Ratio-29.534-145%-12.0363.754-421%11.965-201%-78.009+548%-78.009+548%
Price To Total Gains Ratio-120.221-145%-48.99380.172-161%15.610-414%38.104-229%38.104-229%
Quick Ratio--1.6571.550+7%1.039+59%1.115+49%1.115+49%
Return On Assets--0.004-0.001+131%0.014-72%0.046-92%0.046-92%
Return On Equity--0.007-0.002+133%0.024-72%0.188-96%0.188-96%
Total Gains Per Share---0.663-0.339-49%0.052-1371%0.625-206%0.625-206%
Usd Book Value--191647164.600204369685.200-6%227880620.100-16%158945394.600+21%158945394.600+21%
Usd Book Value Change Per Share---0.701-0.358-49%0.055-1371%0.546-228%0.546-228%
Usd Book Value Per Share--10.92711.596-6%12.634-14%8.870+23%8.870+23%
Usd Dividend Per Share----0%-0%0.114-100%0.114-100%
Usd Eps--0.075-0.026+135%0.269-72%0.859-91%0.859-91%
Usd Free Cash Flow---12510144.000-7851594.600-37%-3697307.550-70%14243020.830-188%14243020.830-188%
Usd Free Cash Flow Per Share---0.713-0.444-38%-0.205-71%0.802-189%0.802-189%
Usd Free Cash Flow To Equity Per Share---0.713-0.444-38%-0.113-84%0.527-235%0.527-235%
Usd Market Cap1464101246.520+59%602277296.927626508296.564-4%921920028.712-35%939114259.014-36%939114259.014-36%
Usd Price Per Share84.264+59%34.34035.549-3%51.071-33%51.179-33%51.179-33%
Usd Profit--1307014.200-465168.150+136%5512018.050-76%15536827.530-92%15536827.530-92%
Usd Revenue--45298555.20041947548.300+8%46252136.700-2%51749045.370-12%51749045.370-12%
Usd Total Gains Per Share---0.701-0.358-49%0.055-1371%0.660-206%0.660-206%
 EOD+4 -4MRQTTM+11 -21YOY+4 -295Y+8 -2710Y+8 -27

3.3 Fundamental Score

Let's check the fundamental score of Pharma Mar SAU based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15282.685
Price to Book Ratio (EOD)Between0-17.712
Net Profit Margin (MRQ)Greater than00.029
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.657
Current Ratio (MRQ)Greater than12.550
Debt to Asset Ratio (MRQ)Less than10.428
Debt to Equity Ratio (MRQ)Less than10.748
Return on Equity (MRQ)Greater than0.150.007
Return on Assets (MRQ)Greater than0.050.004
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Pharma Mar SAU based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.560
Ma 20Greater thanMa 5073.083
Ma 50Greater thanMa 10056.401
Ma 100Greater thanMa 20046.863
OpenGreater thanClose79.750
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Pharma Mar SAU

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

Fundamental data was last updated by Penke on 2024-10-31 11:21:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Pharma Mar SAU earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • A Net Profit Margin of 2.9% means that €0.03 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharma Mar SAU:

  • The MRQ is 2.9%. The company is making a profit. +1
  • The TTM is -1.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ2.9%TTM-1.0%+3.8%
TTM-1.0%YOY11.8%-12.7%
TTM-1.0%5Y24.3%-25.3%
5Y24.3%10Y24.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%-133.6%+136.5%
TTM-1.0%-204.9%+203.9%
YOY11.8%-207.4%+219.2%
5Y24.3%-353.5%+377.8%
10Y24.3%-466.1%+490.4%
4.3.1.2. Return on Assets

Shows how efficient Pharma Mar SAU is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • 0.4% Return on Assets means that Pharma Mar SAU generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharma Mar SAU:

  • The MRQ is 0.4%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.4%TTM-0.1%+0.5%
TTM-0.1%YOY1.4%-1.5%
TTM-0.1%5Y4.6%-4.8%
5Y4.6%10Y4.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%-10.8%+11.2%
TTM-0.1%-11.8%+11.7%
YOY1.4%-11.0%+12.4%
5Y4.6%-12.6%+17.2%
10Y4.6%-14.4%+19.0%
4.3.1.3. Return on Equity

Shows how efficient Pharma Mar SAU is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • 0.7% Return on Equity means Pharma Mar SAU generated €0.01 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharma Mar SAU:

  • The MRQ is 0.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.7%TTM-0.2%+0.9%
TTM-0.2%YOY2.4%-2.7%
TTM-0.2%5Y18.8%-19.0%
5Y18.8%10Y18.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%-13.5%+14.2%
TTM-0.2%-15.9%+15.7%
YOY2.4%-13.5%+15.9%
5Y18.8%-18.6%+37.4%
10Y18.8%-19.0%+37.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pharma Mar SAU.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Pharma Mar SAU is operating .

  • Measures how much profit Pharma Mar SAU makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharma Mar SAU:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY0.6%-0.6%
TTM-5Y21.1%-21.1%
5Y21.1%10Y21.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--277.1%+277.1%
TTM--312.9%+312.9%
YOY0.6%-222.0%+222.6%
5Y21.1%-385.5%+406.6%
10Y21.1%-495.6%+516.7%
4.3.2.2. Operating Ratio

Measures how efficient Pharma Mar SAU is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.07 means that the operating costs are €1.07 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Pharma Mar SAU:

  • The MRQ is 1.066. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.129. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.066TTM1.129-0.062
TTM1.129YOY0.961+0.168
TTM1.1295Y0.854+0.274
5Y0.85410Y0.8540.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0662.842-1.776
TTM1.1293.198-2.069
YOY0.9613.301-2.340
5Y0.8544.800-3.946
10Y0.8546.530-5.676
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pharma Mar SAU.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharma Mar SAU is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.55 means the company has €2.55 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharma Mar SAU:

  • The MRQ is 2.550. The company is able to pay all its short-term debts. +1
  • The TTM is 2.703. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.550TTM2.703-0.153
TTM2.703YOY2.952-0.249
TTM2.7035Y2.674+0.029
5Y2.67410Y2.6740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5503.788-1.238
TTM2.7033.923-1.220
YOY2.9524.711-1.759
5Y2.6745.959-3.285
10Y2.6746.278-3.604
4.4.3.2. Quick Ratio

Measures if Pharma Mar SAU is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • A Quick Ratio of 1.66 means the company can pay off €1.66 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharma Mar SAU:

  • The MRQ is 1.657. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.550. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.657TTM1.550+0.107
TTM1.550YOY1.039+0.511
TTM1.5505Y1.115+0.435
5Y1.11510Y1.1150.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6573.381-1.724
TTM1.5503.526-1.976
YOY1.0394.682-3.643
5Y1.1155.922-4.807
10Y1.1156.458-5.343
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pharma Mar SAU.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Pharma Mar SAU assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharma Mar SAU to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.43 means that Pharma Mar SAU assets are financed with 42.8% credit (debt) and the remaining percentage (100% - 42.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pharma Mar SAU:

  • The MRQ is 0.428. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.423. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.428TTM0.423+0.005
TTM0.423YOY0.426-0.003
TTM0.4235Y0.576-0.153
5Y0.57610Y0.5760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4280.338+0.090
TTM0.4230.347+0.076
YOY0.4260.310+0.116
5Y0.5760.365+0.211
10Y0.5760.381+0.195
4.5.4.2. Debt to Equity Ratio

Measures if Pharma Mar SAU is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • A Debt to Equity ratio of 74.8% means that company has €0.75 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharma Mar SAU:

  • The MRQ is 0.748. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.734. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.748TTM0.734+0.014
TTM0.734YOY0.744-0.010
TTM0.7345Y1.653-0.919
5Y1.65310Y1.6530.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7480.387+0.361
TTM0.7340.437+0.297
YOY0.7440.375+0.369
5Y1.6530.450+1.203
10Y1.6530.489+1.164
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Pharma Mar SAU generates.

  • Above 15 is considered overpriced but always compare Pharma Mar SAU to the Biotechnology industry mean.
  • A PE ratio of 115.20 means the investor is paying €115.20 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharma Mar SAU:

  • The EOD is 282.685. Based on the earnings, the company is expensive. -2
  • The MRQ is 115.201. Based on the earnings, the company is expensive. -2
  • The TTM is 58.495. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD282.685MRQ115.201+167.485
MRQ115.201TTM58.495+56.706
TTM58.495YOY64.500-6.005
TTM58.4955Y33.570+24.925
5Y33.57010Y33.5700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD282.685-2.384+285.069
MRQ115.201-2.428+117.629
TTM58.495-2.991+61.486
YOY64.500-3.440+67.940
5Y33.570-6.006+39.576
10Y33.570-6.278+39.848
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharma Mar SAU:

  • The EOD is -29.534. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.036. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 3.754. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-29.534MRQ-12.036-17.498
MRQ-12.036TTM3.754-15.790
TTM3.754YOY11.965-8.211
TTM3.7545Y-78.009+81.763
5Y-78.00910Y-78.0090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-29.534-3.160-26.374
MRQ-12.036-3.222-8.814
TTM3.754-3.516+7.270
YOY11.965-4.582+16.547
5Y-78.009-8.076-69.933
10Y-78.009-8.950-69.059
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Pharma Mar SAU is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.14 means the investor is paying €3.14 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharma Mar SAU:

  • The EOD is 7.712. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.143. Based on the equity, the company is fair priced.
  • The TTM is 3.072. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.712MRQ3.143+4.569
MRQ3.143TTM3.072+0.071
TTM3.072YOY4.029-0.957
TTM3.0725Y4.373-1.301
5Y4.37310Y4.3730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.7121.964+5.748
MRQ3.1431.983+1.160
TTM3.0722.197+0.875
YOY4.0292.404+1.625
5Y4.3733.596+0.777
10Y4.3734.223+0.150
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets317,102
Total Liabilities135,721
Total Stockholder Equity181,381
 As reported
Total Liabilities 135,721
Total Stockholder Equity+ 181,381
Total Assets = 317,102

Assets

Total Assets317,102
Total Current Assets224,113
Long-term Assets92,989
Total Current Assets
Cash And Cash Equivalents 19,319
Short-term Investments 115,828
Net Receivables 29,801
Inventory 47,247
Other Current Assets 11,560
Total Current Assets  (as reported)224,113
Total Current Assets  (calculated)223,755
+/- 358
Long-term Assets
Property Plant Equipment 54,738
Long-term Assets  (as reported)92,989
Long-term Assets  (calculated)54,738
+/- 38,251

Liabilities & Shareholders' Equity

Total Current Liabilities87,874
Long-term Liabilities47,847
Total Stockholder Equity181,381
Total Current Liabilities
Short Long Term Debt 10,321
Accounts payable 32,815
Other Current Liabilities 20,348
Total Current Liabilities  (as reported)87,874
Total Current Liabilities  (calculated)63,484
+/- 24,390
Long-term Liabilities
Long term Debt 26,028
Capital Lease Obligations Min Short Term Debt3,034
Long-term Liabilities Other 196
Long-term Liabilities  (as reported)47,847
Long-term Liabilities  (calculated)29,258
+/- 18,589
Total Stockholder Equity
Retained Earnings 144,433
Total Stockholder Equity (as reported)181,381
Total Stockholder Equity (calculated)144,433
+/- 36,948
Other
Capital Stock11,013
Common Stock Shares Outstanding 17,539
Net Debt 17,030
Net Invested Capital 217,730
Net Working Capital 136,239
Property Plant and Equipment Gross 54,738



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
112,537
124,705
275,611
352,227
329,731
330,259
345,102
342,542
347,692
368,386
378,028
390,772
379,098
393,259
373,717
358,690
349,412
340,520
333,898
317,102
317,102333,898340,520349,412358,690373,717393,259379,098390,772378,028368,386347,692342,542345,102330,259329,731352,227275,611124,705112,537
   > Total Current Assets 
50,751
49,976
202,583
259,470
237,859
245,651
261,420
276,683
280,941
295,231
289,149
274,689
265,939
275,183
257,475
267,839
260,973
252,602
241,357
224,113
224,113241,357252,602260,973267,839257,475275,183265,939274,689289,149295,231280,941276,683261,420245,651237,859259,470202,58349,97650,751
       Cash And Cash Equivalents 
23,409
17,638
153,992
208,892
93,222
96,210
106,432
129,587
132,167
113,348
152,255
142,723
129,433
149,813
119,711
76,070
69,975
60,024
35,709
19,319
19,31935,70960,02469,97576,070119,711149,813129,433142,723152,255113,348132,167129,587106,43296,21093,222208,892153,99217,63823,409
       Short-term Investments 
3,597
3,257
19,612
19,214
104,023
99,306
103,627
87,145
88,947
88,532
69,333
53,973
56,917
32,607
63,416
108,826
104,378
102,538
124,010
115,828
115,828124,010102,538104,378108,82663,41632,60756,91753,97369,33388,53288,94787,145103,62799,306104,02319,21419,6123,2573,597
       Net Receivables 
11,682
11,530
16,793
18,247
27,452
24,054
26,850
27,853
26,036
50,908
30,801
32,320
29,154
29,328
24,447
25,936
30,182
27,203
26,945
29,801
29,80126,94527,20330,18225,93624,44729,32829,15432,32030,80150,90826,03627,85326,85024,05427,45218,24716,79311,53011,682
       Inventory 
8,541
8,902
8,725
9,576
8,574
11,933
8,722
10,744
10,539
10,536
15,733
18,590
21,507
27,746
32,618
35,559
34,892
39,289
43,478
47,247
47,24743,47839,28934,89235,55932,61827,74621,50718,59015,73310,53610,53910,7448,72211,9338,5749,5768,7258,9028,541
       Other Current Assets 
3,522
7,314
3,461
3,541
4,588
13,151
15,789
21,354
23,252
27,999
21,027
27,083
28,928
29,709
17,283
20,896
21,546
14,067
11,215
11,560
11,56011,21514,06721,54620,89617,28329,70928,92827,08321,02727,99923,25221,35415,78913,1514,5883,5413,4617,3143,522
   > Long-term Assets 
61,786
74,729
73,028
92,757
91,872
84,608
83,681
65,859
66,751
73,155
88,879
116,083
113,159
118,076
116,242
90,851
88,439
87,918
92,541
92,989
92,98992,54187,91888,43990,851116,242118,076113,159116,08388,87973,15566,75165,85983,68184,60891,87292,75773,02874,72961,786
       Property Plant Equipment 
0
25,602
24,985
25,118
24,990
24,745
26,753
27,180
28,745
26,896
30,639
30,077
27,688
34,715
34,148
39,186
43,006
47,607
53,740
54,738
54,73853,74047,60743,00639,18634,14834,71527,68830,07730,63926,89628,74527,18026,75324,74524,99025,11824,98525,6020
       Intangible Assets 
3,949
6,074
5,287
4,785
0
3,860
0
0
0
3,233
0
0
0
2,589
0
0
0
1,935
0
0
001,9350002,5890003,2330003,86004,7855,2876,0743,949
       Long-term Assets Other 
1
0
1
1
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001011101
> Total Liabilities 
121,746
117,249
198,229
248,729
231,581
227,537
217,577
207,688
204,487
190,468
176,227
183,836
166,594
170,302
156,786
148,388
143,217
147,082
141,224
135,721
135,721141,224147,082143,217148,388156,786170,302166,594183,836176,227190,468204,487207,688217,577227,537231,581248,729198,229117,249121,746
   > Total Current Liabilities 
60,768
60,439
103,758
108,447
105,723
94,919
83,793
77,334
81,444
86,346
80,648
96,087
89,940
97,320
89,029
85,509
86,625
95,888
92,270
87,874
87,87492,27095,88886,62585,50989,02997,32089,94096,08780,64886,34681,44477,33483,79394,919105,723108,447103,75860,43960,768
       Short Long Term Debt 
28,722
29,655
17,004
18,524
17,051
15,313
16,235
16,152
14,368
12,212
12,183
10,736
13,776
13,125
13,213
12,748
12,777
12,825
10,920
10,321
10,32110,92012,82512,77712,74813,21313,12513,77610,73612,18312,21214,36816,15216,23515,31317,05118,52417,00429,65528,722
       Accounts payable 
19,198
16,471
15,002
15,170
15,987
21,039
20,696
13,625
19,160
26,928
26,353
24,689
31,117
27,492
21,075
23,134
21,284
29,174
34,631
32,815
32,81534,63129,17421,28423,13421,07527,49231,11724,68926,35326,92819,16013,62520,69621,03915,98715,17015,00216,47119,198
       Other Current Liabilities 
2,406
4,974
64,440
68,700
64,522
48,310
40,891
40,775
38,512
35,884
35,483
53,223
35,326
44,383
23,187
16,105
17,351
15,840
19,571
20,348
20,34819,57115,84017,35116,10523,18744,38335,32653,22335,48335,88438,51240,77540,89148,31064,52268,70064,4404,9742,406
   > Long-term Liabilities 
60,978
56,810
109,473
140,283
125,858
132,618
133,784
130,354
123,043
104,122
95,579
87,749
76,654
72,982
67,757
62,879
56,592
51,194
48,954
47,847
47,84748,95451,19456,59262,87967,75772,98276,65487,74995,579104,122123,043130,354133,784132,618125,858140,283109,47356,81060,978
       Long term Debt 
56,897
53,063
43,554
40,927
39,865
37,732
34,132
37,160
36,352
33,386
31,417
30,291
26,059
25,883
26,562
27,060
26,873
27,036
25,886
26,028
26,02825,88627,03626,87327,06026,56225,88326,05930,29131,41733,38636,35237,16034,13237,73239,86540,92743,55453,06356,897
       Capital Lease Obligations Min Short Term Debt
3,708
3,397
3,076
3,390
3,357
3,620
4,021
3,919
3,784
3,735
4,097
3,593
2,583
3,622
3,613
3,870
3,928
3,808
3,454
3,034
3,0343,4543,8083,9283,8703,6133,6222,5833,5934,0973,7353,7843,9194,0213,6203,3573,3903,0763,3973,708
       Other Liabilities 
0
2,028
49,399
97,457
84,209
92,736
97,382
91,073
84,698
68,820
62,219
55,871
49,369
45,085
0
0
0
0
0
0
00000045,08549,36955,87162,21968,82084,69891,07397,38292,73684,20997,45749,3992,0280
       Long-term Liabilities Other 
177
177
15,174
174
175
176
177
178
182
186
188
184
184
186
189
191
191
193
194
196
19619419319119118918618418418818618217817717617517415,174177177
       Deferred Long Term Liability 
0
5,151
0
0
0
2,807
0
0
0
2,105
0
0
0
1,403
0
0
0
0
0
0
0000001,4030002,1050002,8070005,1510
> Total Stockholder Equity
-5,296
11,374
81,304
107,434
98,150
102,722
127,525
134,854
143,205
177,918
201,801
206,936
212,504
222,957
216,931
210,302
206,195
193,438
192,674
181,381
181,381192,674193,438206,195210,302216,931222,957212,504206,936201,801177,918143,205134,854127,525102,72298,150107,43481,30411,374-5,296
   Common Stock
0
11,132
11,132
11,132
11,132
11,013
11,013
11,013
11,013
11,013
11,013
11,013
11,013
11,013
0
0
0
0
0
0
00000011,01311,01311,01311,01311,01311,01311,01311,01311,01311,13211,13211,13211,1320
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
15
11
14
14
14
16
16
17
19
20
21
22
19
0
0
0
0
0
0
000000192221201917161614141411150



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue158,153
Cost of Revenue-9,613
Gross Profit148,540148,540
 
Operating Income (+$)
Gross Profit148,540
Operating Expense-162,251
Operating Income-4,098-13,711
 
Operating Expense (+$)
Research Development99,302
Selling General Administrative41,805
Selling And Marketing Expenses0
Operating Expense162,251141,107
 
Net Interest Income (+$)
Interest Income4,103
Interest Expense-2,416
Other Finance Cost-0
Net Interest Income1,687
 
Pretax Income (+$)
Operating Income-4,098
Net Interest Income1,687
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,623-4,098
EBIT - interestExpense = -2,416
1,137
3,553
Interest Expense2,416
Earnings Before Interest and Taxes (EBIT)0-1,207
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,623
Tax Provision--4,760
Net Income From Continuing Ops1,1371,137
Net Income1,137
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,687
 

Technical Analysis of Pharma Mar SAU
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharma Mar SAU. The general trend of Pharma Mar SAU is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharma Mar SAU's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharma Mar SAU.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 70.35 > 68.30 > 65.21.

Tweet this
Pharma Mar SAU Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharma Mar SAU. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharma Mar SAU Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharma Mar SAU. The current macd is 6.34004347.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharma Mar SAU price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharma Mar SAU. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharma Mar SAU price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Pharma Mar SAU Daily Moving Average Convergence/Divergence (MACD) ChartPharma Mar SAU Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharma Mar SAU. The current adx is 55.54.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharma Mar SAU shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Pharma Mar SAU Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharma Mar SAU. The current sar is 74.33.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Pharma Mar SAU Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharma Mar SAU. The current rsi is 76.56. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Pharma Mar SAU Daily Relative Strength Index (RSI) ChartPharma Mar SAU Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharma Mar SAU. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharma Mar SAU price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pharma Mar SAU Daily Stochastic Oscillator ChartPharma Mar SAU Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharma Mar SAU. The current cci is 171.18.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Pharma Mar SAU Daily Commodity Channel Index (CCI) ChartPharma Mar SAU Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharma Mar SAU. The current cmo is 51.92.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Pharma Mar SAU Daily Chande Momentum Oscillator (CMO) ChartPharma Mar SAU Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharma Mar SAU. The current willr is -6.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Pharma Mar SAU Daily Williams %R ChartPharma Mar SAU Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pharma Mar SAU.

Pharma Mar SAU Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharma Mar SAU. The current atr is 1.74488743.

Pharma Mar SAU Daily Average True Range (ATR) ChartPharma Mar SAU Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharma Mar SAU. The current obv is 5,631.

Pharma Mar SAU Daily On-Balance Volume (OBV) ChartPharma Mar SAU Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharma Mar SAU. The current mfi is 60.38.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Pharma Mar SAU Daily Money Flow Index (MFI) ChartPharma Mar SAU Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharma Mar SAU.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-22 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-26 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-22 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-27 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-16 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Pharma Mar SAU Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharma Mar SAU based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.560
Ma 20Greater thanMa 5073.083
Ma 50Greater thanMa 10056.401
Ma 100Greater thanMa 20046.863
OpenGreater thanClose79.750
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharma Mar SAU with someone you think should read this too:
  • Are you bullish or bearish on Pharma Mar SAU? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharma Mar SAU? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharma Mar SAU

I send you an email if I find something interesting about Pharma Mar SAU.


Comments

How you think about this?

Leave a comment

Stay informed about Pharma Mar SAU.

Receive notifications about Pharma Mar SAU in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.